Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2018-09-25 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于股东减持公司股份的提示性公告
Director's Dealing Classification · 100% confidence The document is a notification about a shareholder's reduction in company shares, detailing the number of shares sold, dates, prices, and compliance with relevant securities regulations. It includes specific information about the shareholder's holdings before and after the reduction. The document is titled as a '提示性公告' (informative announcement) regarding share reduction by a shareholder. This fits the definition of a 'Director's Dealing' or insider share transaction report, as it reports personal share transactions by a company director or significant shareholder. The document is short (1275 characters) and focused solely on share reduction details, not a full financial report or other type of filing.
2018-09-25 Chinese
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the pledge of shares by a controlling shareholder, including details about the number of shares pledged, the pledgee, and the purpose. It does not contain financial statements, earnings data, or management discussion. It is a regulatory announcement about a shareholder's share pledge, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement about share pledge and does not fit other more specific categories like Major Shareholding Notification (MRQ) which typically involves changes in ownership thresholds rather than pledges.
2018-09-21 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the shareholder's total holdings, and the percentage of shares pledged. There is no financial report, earnings data, or management discussion. The content focuses on a specific shareholder's share pledge transaction, which is a capital structure update related to financing or collateral arrangements. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is short and contains detailed information about the share pledge, not just an announcement of a report, so it is not RPA or RNS.
2018-09-20 Chinese
关于控股股东部分股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by a controlling shareholder. It details the number of shares released from pledge, the dates, and the shareholder's total shareholding and pledge status. There is no financial report, earnings data, or management discussion. The content fits the category of a capital structure update related to share pledges. Therefore, it is best classified as a Capital/Financing Update (CAP). The document length is short and focused on share pledge release, not a report publication or regulatory filing. Confidence is high due to clear content matching the CAP category.
2018-09-19 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the pledgee, and the proportion of shares involved. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge activity, which fits the category of Capital/Financing Update (CAP). The document length is short and focused on share pledge details, not a report publication or certification. Therefore, the classification is CAP with high confidence.
2018-09-18 Chinese
风险提示公告
Regulatory Filings Classification · 95% confidence The document is a risk warning announcement from a company (福安药业) regarding operational risks related to its subsidiary's products and potential impacts on financial performance. It discusses market competition, product safety issues, regulatory inspections, and possible goodwill impairment. The document does not contain financial statements or detailed financial data but serves as a disclosure of risks and caution to investors. It is relatively short (1923 characters) and does not present itself as a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and risk disclosures that do not fit other specific categories.
2018-09-14 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.